BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Takeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device

  Takeda inked a collaboration deal to develop and commercialize Portal’s needle-free drug delivery device for use with some of Takeda’s biologic medicines.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Beach

  Puma Biotech Locks in $100M Loan to Market Newly-Approved Breast Cancer Drug

  Puma received gross proceeds of $50 million from the first tranche of the credit facility upon closing on Oct. 31.

  November 7, 2017

   · 

  1 min read
• 

  Business

  Roche Lays Off 235 Employees in Switzerland

  The jobs are being cut because Roche is moving Swiss packaging ops to CMO-divested sites.

  November 7, 2017

   · 

  1 min read
• 

  BioMidwest

  The Lone 3 Big Pharmas That Will Gain Market Share Over the Next Few Years

  With worldwide spending on prescription drugs increasing from an estimated $774B in 2017 to over $1 trillion in 2022, a rising tide of pharmaceutical sales is lifting a lot of drug company boats and creating plenty of opportunities for investors.

  November 7, 2017

   · 

  1 min read
• 

  Policy

  FDA Slaps Warning Letters on Two Lupin Plants

  The FDA issued warning letters to Lupin for two of its manufacturing facilities in Goa and Pithampur, Indore.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  San Diego Biotech Progenity Banks $125M for Precision Medicine R&D

  Progenity snagged $125M in funding that will allow the company to accelerate development of its gastrointestinal platform.

  November 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Of 3,500 Eli Lilly Worldwide Job Cuts, 2,300 in U.S. Took Voluntary Severance

  The cuts were expected to save the company $500M.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Senator Harris Scrutinizes How Alkermes Pushed Its Opioid Addiction Drug

  Harris fired the first shots on Monday.

  November 7, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Confident Bristol-Myers to Launch 700-Patient Phase III IDO Trial for Melanoma

  Bristol-Myers is initiating a Phase III clinical trial of BMS-986205 with nivolumab in patients with advanced melanoma.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Massachusetts’ Haemonetics to Eliminate 350 Jobs

  Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort.

  November 7, 2017

   · 

  2 min read

   · 

  Alex Keown